Cargando…
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice
Bone strength – and, hence, fracture risk – reflects the structural and material properties of the skeleton, which changes with bone turnover during aging and following effective pharmacotherapy. A variety of powerful new techniques (quantitative computed tomography, as well as peripheral quantitati...
Autores principales: | Cheung, Angela M, Frame, Heather, Ho, Michael, Mackinnon, Erin S, Brown, Jacques P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047712/ https://www.ncbi.nlm.nih.gov/pubmed/27729815 http://dx.doi.org/10.2147/IJWH.S112621 |
Ejemplares similares
-
Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women
por: Jordan, Natasha, et al.
Publicado: (2006) -
New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015) -
Bone‐Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
por: Chavassieux, Pascale, et al.
Publicado: (2019) -
Antiresorptive Agents Increase the Effects of Exercise on Preventing Postmenopausal Bone Loss in Women: A Meta-Analysis
por: Zhao, Renqing, et al.
Publicado: (2015) -
The influence of antiresorptive bone medication on the effect of high-intensity resistance and impact training on osteoporotic fracture risk in postmenopausal women with low bone mass: protocol for the MEDEX-OP randomised controlled trial
por: Fischbacher, Melanie, et al.
Publicado: (2019)